SMS Co., Ltd.

2175.T
Health Information Services
2026/08/24 Updated
Market Cap: $1.2B (¥194.5B)
Stock Price: $14.88 (¥2,370)
Exchange Rate: 1 USD = ¥159.24

Fiscal Year Ending March 2026 Financial Results and Company Presentation

For the fiscal year ending March 2026, net sales were JPY 64.7 billion (YoY +6%), operating income JPY 6.7 billion (YoY +7%), EBITDA JPY 11.4 billion (YoY +11%), and net income attributable to owners of parent was a loss of JPY 14.3 billion.

Importance:
Page Updated: April 28, 2026
IR Disclosure Date: April 28, 2026

Key Figures

  • Net Sales: JPY 64.7 billion (YoY +6%)
  • Operating Income: JPY 6.7 billion (YoY +7%)
  • Net Income Attributable to Owners of Parent: Loss of JPY 14.3 billion (including JPY 22.9 billion impairment loss in overseas operations)

AI要約

Summary of Fiscal Year Ending March 2026 Financial Results

For the fiscal year ending March 2026, net sales increased to JPY 64.7 billion (YoY +6%), operating income rose to JPY 6.7 billion (YoY +7%), and EBITDA reached JPY 11.4 billion (YoY +11%). However, due to impairment losses of JPY 22.9 billion recorded in overseas operations, net income attributable to owners of parent resulted in a loss of JPY 14.3 billion. The dividend forecast remains unchanged at JPY 29.5 per share, representing an increase of JPY 1.0 from the previous fiscal year.

Roadmap to Maximizing Corporate Value and Future Outlook

A medium-term management plan has been formulated with targets for the fiscal year ending March 2031 of achieving net sales exceeding JPY 122.0 billion, EBITDA exceeding JPY 28.0 billion, and ROE above 30%. Profit indicators during the expanded phase of M&A and software investments have been shifted to EBITDA, and a Corporate Value Enhancement Committee has been established. Detailed medium-term management plans are scheduled to be announced by the full-year financial results for the fiscal year ending March 2027. While advancing growth investments and strengthening the sales structure, a fundamental review of operations is underway in response to impairment losses in overseas businesses.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

S.M.S. Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →